IMCR
Price
$33.93
Change
-$0.29 (-0.85%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
1.72B
28 days until earnings call
KYMR
Price
$56.33
Change
-$0.59 (-1.04%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
4.07B
22 days until earnings call
Interact to see
Advertisement

IMCR vs KYMR

Header iconIMCR vs KYMR Comparison
Open Charts IMCR vs KYMRBanner chart's image
Immunocore Holdings
Price$33.93
Change-$0.29 (-0.85%)
Volume$8.54K
Capitalization1.72B
Kymera Therapeutics
Price$56.33
Change-$0.59 (-1.04%)
Volume$9.73K
Capitalization4.07B
IMCR vs KYMR Comparison Chart in %
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMCR vs. KYMR commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMCR is a Hold and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (IMCR: $34.22 vs. KYMR: $56.92)
Brand notoriety: IMCR and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMCR: 92% vs. KYMR: 41%
Market capitalization -- IMCR: $1.72B vs. KYMR: $4.07B
IMCR [@Biotechnology] is valued at $1.72B. KYMR’s [@Biotechnology] market capitalization is $4.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMCR’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • IMCR’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, IMCR is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMCR’s TA Score shows that 5 TA indicator(s) are bullish while KYMR’s TA Score has 6 bullish TA indicator(s).

  • IMCR’s TA Score: 5 bullish, 5 bearish.
  • KYMR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than IMCR.

Price Growth

IMCR (@Biotechnology) experienced а -5.81% price change this week, while KYMR (@Biotechnology) price change was +0.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.11%. For the same industry, the average monthly price growth was +19.03%, and the average quarterly price growth was +87.04%.

Reported Earning Dates

IMCR is expected to report earnings on Nov 05, 2025.

KYMR is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+9.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.07B) has a higher market cap than IMCR($1.72B). KYMR YTD gains are higher at: 41.486 vs. IMCR (16.000). IMCR has higher annual earnings (EBITDA): -1.31M vs. KYMR (-267.03M). IMCR has more cash in the bank: 883M vs. KYMR (665M). KYMR has less debt than IMCR: KYMR (85.7M) vs IMCR (436M). IMCR has higher revenues than KYMR: IMCR (356M) vs KYMR (44.7M).
IMCRKYMRIMCR / KYMR
Capitalization1.72B4.07B42%
EBITDA-1.31M-267.03M0%
Gain YTD16.00041.48639%
P/E RatioN/AN/A-
Revenue356M44.7M796%
Total Cash883M665M133%
Total Debt436M85.7M509%
TECHNICAL ANALYSIS
Technical Analysis
IMCRKYMR
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 6 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BACIX14.38N/A
N/A
BlackRock Energy Opportunities Instl
LOGSX21.94N/A
N/A
Live Oak Health Sciences
VTRIX47.25N/A
N/A
Vanguard International Value Inv
MTERX63.93N/A
N/A
MFS Technology R2
TAVZX73.66N/A
N/A
Third Avenue Value Z

IMCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMCR has been loosely correlated with NUVL. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IMCR jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCR
1D Price
Change %
IMCR100%
+0.62%
NUVL - IMCR
53%
Loosely correlated
-0.56%
NRIX - IMCR
49%
Loosely correlated
-1.21%
CGON - IMCR
46%
Loosely correlated
-0.34%
KYMR - IMCR
46%
Loosely correlated
-1.09%
IDYA - IMCR
46%
Loosely correlated
-2.07%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-1.09%
NRIX - KYMR
67%
Closely correlated
-1.21%
VERA - KYMR
60%
Loosely correlated
-0.45%
CGON - KYMR
56%
Loosely correlated
-0.34%
NUVL - KYMR
55%
Loosely correlated
-0.56%
RGNX - KYMR
55%
Loosely correlated
-1.68%
More